Table 2.
Definitions of response in CP-CML patients treated with imatinib as defined by the ELN4
NA indicates not applicable and CHR, complete hematologic response.
Definitions of response in CP-CML patients treated with imatinib as defined by the ELN4
NA indicates not applicable and CHR, complete hematologic response.
